A meta-analysis of the association between adherence to drug therapy and mortality -- Simpson et al. 333 (7557): 15 Data Supplement - References w1

References for included studies [as supplied by authors]

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980;303:1038-41.
Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990;336:542-5.
Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. Journal of the American Medical Association 1993;270:742-4.
Obias-Manno D, Friedmann E, Brooks MM, Thomas SA, Haakenson C, Morris M, et al. Adherence and arrhythmic mortality in the Cardiac Arrhythmia Suppression Trial (CAST). Annals of Epidemiology 1996;6:93-101.
Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart 2002;88:229-33.
Cotter G, Shemesh E, Zehavi M, Dinur I, Rudnick A, Milo O, et al. Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin? American Heart Journal 2004;147:293-300.
Wei L, Flynn R, Murray GD, McDonald TM. Use and adherence to beta-blockers for secondary prevention of myocardial infarction: Who is not getting the treatment? Pharmacoepidemiology & Drug Safety 2004;13:761-6.
Irvine J, Baker B, Smith J, Jandciu S, Paquette M, Cairns J, et al. Poor adherence to placebo or amiodarone therapy predicts mortality: results from the CAMIAT study. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. Psychosomatic Medicine 1999;61:566-75.
San Andres Rebollo FJ, Rubio Garcia R, Castilla Catalan J, Pulido Ortega F, Palao G, de Pedro Andres I, et al. Mortality and survival in a cohort of 1,115 HIV-infected patients (1989-97). Anales de Medicina Interna 2004;21:523-32.
Cohn SE, Kammann E, Williams P, Currier JS, Chesney MA. Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in acquired immunodeficiency syndrome. Clinical Infectious Diseases 2002;34:1129-36.
Garcia de Olalla P, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes 2002;30:105-10.
Grimwade K, Sturm AW, Nunn AJ, Mbatha D, Zungu D, Gilks CF. Effectiveness of cotrimoxazole prophylaxis on mortality in adults with tuberculosis in rural South Africa. AIDS 2005;19:163-8.
Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O’Shaughnessy MV, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS 2002;16:1051-8.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 2000;133:21-30.
Wood E, Hogg RS, Yip B, Harrigan PR, O’Shaughnessy MV, Montaner JSG. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4(+) cell count is 0.200 to 0.350 X 10(9) cells/L. Annals of Internal Medicine 2003;139:810-6.
Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH. Adherence to aspirin in the prevention of myocardial infarction. The Physicians’ Health Study. Archives of Internal Medicine 1994;154:2649-57.
Shepherd J, Cobbe SM, Lorimer AR, McKillop JH, Ford I, Packard CJ, et al. Compliance and adverse event withdrawal: Their impact on the West of Scotland Coronary Prevention Study. European Heart Journal 1997;18:1718-24.
Cornfield J. The University Group Diabetes Program. A further statistical analysis of the mortality findings. Journal of the American Medical Association 1971;217:1676-87.
Howell N, Trotter R, Mottram DR, Rowe D. Compliance with statins in primary care. Pharmaceutical Journal 2004;272:23-6.
Miura T, Kojima R, Mizutani M, Shiga Y, Takatsu F, Suzuki Y. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: A prospective cohort study. European Journal of Clinical Pharmacology 2001;57:77-83.
Dobbels F, De Geest S, Van Cleemput J, Droogne W, Vanhaecke J. Effect of late medication non-compliance on outcome after heart transplantation: A 5-year follow-up. Journal of Heart and Lung Transplantation 2004;23:1245-51.
Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970;19:789-830.

Dr. Simpson is a New Investigator supported by the Canadian Institutes of Health Research (CIHR). Mr. Eurich holds a Doctoral Research award with CIHR and a Full-time Studentship in Health Research with the Alberta Heritage Foundation for Medical Research (AHFMR). Dr. Majumdar is a New Investigator supported by CIHR and a Population Health Investigator with AHFMR. Dr. Tsuyuki holds the Merck Frosst Chair in Patient Health Management from the Faculty of Pharmacy and Pharmaceutical Sciences and Faculty of Medicine and Dentistry, University of Alberta. Dr. Johnson holds a Canada Research Chair in Diabetes Health Outcomes, is a Health Scholar supported by AHFMR, and is Chair of a New Emerging Team (NET) grant to the Alliance for Canadian Health Outcomes Research in Diabetes (ACHORD). The ACHORD NET grant is sponsored by the Canadian Diabetes Association, the Heart and Stroke Foundation of Canada, The Kidney Foundation of Canada, and the CIHR – (Nutrition, Metabolism and Diabetes; and, Circulatory and Respiratory Health).